<html>
<head>PUBMED IDs for NLF2</head>
<body bgcolor='#C5F0F2'><h1>NLF2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/9195985/'>A CACCC box-like cis-regulatory element of the Epstein-Barr virus ED-L2 promoter interacts with a novel transcriptional factor in tissue-specific squamous epithelia.</a> June 27  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/15527968/'>A novel gene family induced by acute inflammation in endothelial cells.</a> November 6  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/17620360/'>A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates.</a> July 11  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18977445/'>Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products.</a> November 4  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19201886/'>Specific targeting of the EBV lytic phase protein BNLF2a to the transporter associated with antigen processing results in impairment of HLA class I-restricted antigen presentation.</a> March 5  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19557156/'>Stage-specific inhibition of MHC class I presentation by the Epstein-Barr virus BNLF2a protein during virus lytic cycle.</a> September 22  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19557147/'>The link between human and transgenic animal studies involving postprandial hypertriglyceridemia and CETP gene polymorphisms.</a> June 27  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20980626/'>CD8+ T cell responses against TAP-inhibited cells are readily detected in the human population.</a> January 11  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/22543160/'>RNAs in Epstein-Barr virions control early steps of infection.</a> August 3  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22543157/'>Next generation exome sequencing of paediatric inflammatory bowel disease patients identifies rare and novel variants in candidate genes.</a> August 28  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22615564/'>The EBV immunoevasins vIL-10 and BNLF2a protect newly infected B cells from immune recognition and elimination.</a> November 9  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22885067/'>NLF2 gene expression in the endometrium of patients with implantation failure after IVF treatment.</a> November 9  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/25144360/'>Cooperation between Epstein-Barr virus immune evasion proteins spreads protection from CD8+ T cell recognition across all three phases of the lytic cycle.</a> December 22  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25959517/'>Sequence analysis of EBV immune evasion gene BNLF2a in EBV associated tumors and healthy individuals from nasopharyngeal carcinoma endemic and non-endemic regions of China.</a> May 26  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26178981/'>Latent Expression of the Epstein-Barr Virus (EBV)-Encoded Major Histocompatibility Complex Class I TAP Inhibitor, BNLF2a, in EBV-Positive Gastric Carcinomas.</a> December 15  2015<br></body></html>
